Five charts cut through the summer market noise, revealing rising speculation, changing inflation dynamics, and a broader global opportunity set.
Insights
Our latest thinking on the themes shaping today’s investment landscape. Explore timely updates, quarterly features and in-depth analysis straight from our experts.
After a notable pickup toward the end of last year, biopharma M&A and IPO activity have accelerated in 2026.
How spread tightness requires a more thorough search for value, even among less loved sectors.
A monthly market update featuring global equity and fixed income performance, sector and asset class trends, and key themes shaping the investment landscape.
As liquidity conditions evolve and profit growth expands globally, opportunities are emerging beyond the Magnificent 7 and other momentum-driven market leaders.
Robert Schramm-Fuchs explores the outlook for European equities, highlighting earnings momentum, attractive valuations, market rotation, and key stock selection opportunities.
Why floating-rate CLOs have continued to be the best-performing assets in global fixed income markets.
Why CLOs are well positioned for the current investment backdrop.
Healthcare’s mix of innovation and defensive characteristics is helping support a compelling opportunity set for investors.
Stronger earnings forecasts are challenging the valuation discount between global small caps and large caps.
Cybersecurity’s evolution into critical AI infrastructure.